Garau J - Search Results

1

Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence.

Ball P, Baquero F, Cars O, File T, Garau J, Klugman K, Low DE, Rubinstein E, Wise R; Consensus Group on Resistance and Prescribing in Respiratory Tract Infection. Ball P, et al. Among authors: garau j. J Antimicrob Chemother. 2002 Jan;49(1):31-40. doi: 10.1093/jac/49.1.31. J Antimicrob Chemother. 2002. PMID: 11751764 Review.

2

Future trends in antimicrobial chemotherapy: expert opinion on the 43rd ICAAC.

Ball AP, Bartlett JG, Craig WA, Drusano GL, Felmingham D, Garau JA, Klugman KP, Low DE, Mandell LA, Rubinstein E, Tillotson GS. Ball AP, et al. Among authors: garau ja. J Chemother. 2004 Oct;16(5):419-36. doi: 10.1179/joc.2004.16.5.419. J Chemother. 2004. PMID: 15565907 Review.

3

Efficacy and safety of gemifloxacin in the treatment of community-acquired pneumonia: a randomized, double-blind comparison with trovafloxacin.

File TM Jr, Schlemmer B, Garau J, Cupo M, Young C; 049 Clinical Study Group. File TM Jr, et al. Among authors: garau j. J Antimicrob Chemother. 2001 Jul;48(1):67-74. doi: 10.1093/jac/48.1.67. J Antimicrob Chemother. 2001. PMID: 11474633 Clinical Trial.

4

Gemifloxacin versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis. The 070 Clinical Study group.

File T, Schlemmer B, Garau J, Lode H, Lynch S, Young C. File T, et al. Among authors: garau j. J Chemother. 2000 Aug;12(4):314-25. doi: 10.1179/joc.2000.12.4.314. J Chemother. 2000. PMID: 10949981 Clinical Trial.

5

Implications of antimicrobial resistance in the empirical treatment of community-acquired respiratory tract infections: the case of macrolides.

Lonks JR, Garau J, Medeiros AA. Lonks JR, et al. Among authors: garau j. J Antimicrob Chemother. 2002 Dec;50 Suppl S2:87-92. doi: 10.1093/jac/dkf512. J Antimicrob Chemother. 2002. PMID: 12556438 Review.

6

Improving care for patients with respiratory tract infections.

Lode H, Garau J. Lode H, et al. Among authors: garau j. J Chemother. 2002 Feb;14 Suppl 2:22-8. J Chemother. 2002. PMID: 12003137 Review.

7

Global and local variations in antimicrobial susceptibilities and resistance development in the major respiratory pathogens.

Alpuche C, Garau J, Lim V. Alpuche C, et al. Among authors: garau j. Int J Antimicrob Agents. 2007 Dec;30 Suppl 2:S135-8. doi: 10.1016/j.ijantimicag.2007.07.035. Epub 2007 Oct 22. Int J Antimicrob Agents. 2007. PMID: 17945468 Review.

8

The role of glycopeptide antibiotics in the treatment of infective endocarditis.

Grüneberg RN, Antunes F, Chambers HF, Garau J, Graninger W, Menichetti F, Peetermans WE, Pittet D, Shah PM, Vogelaers D. Grüneberg RN, et al. Among authors: garau j. Int J Antimicrob Agents. 1999 Aug;12(3):191-8. doi: 10.1016/s0924-8579(99)00006-0. Int J Antimicrob Agents. 1999. PMID: 10461836 Review.

9

Marking November 12, 2010 - World Pneumonia Day: where are we, where are vaccines?

Dagan R, de Quadros CA, Garau J, Klugman KP, Khuri-Bulos N, Levine O, Sow S, Yang Y. Dagan R, et al. Among authors: garau j. Hum Vaccin. 2010 Nov;6(11):922-5. doi: 10.4161/hv.6.11.13599. Epub 2010 Nov 1. Hum Vaccin. 2010. PMID: 21045539 No abstract available.

10

The remaining challenge of pneumonia: the leading killer of children.

Dagan R, Bhutta ZA, de Quadros CA, Garau J, Klugman KP, Khuri-Bulos N, Levine O, Saha SK, Sow S, Were F, Yang Y. Dagan R, et al. Among authors: garau j. Pediatr Infect Dis J. 2011 Jan;30(1):1-2. doi: 10.1097/INF.0b013e3182005389. Pediatr Infect Dis J. 2011. PMID: 21076365 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

257 results

Search Page